SR ONE CAPITAL MANAGEMENT, LLC
SR ONE CAPITAL MANAGEMENT, LLC has made 1 open-market purchase worth $27.2M since Sep 30, 2026, in 1 company. The latest: $27.2M of ADRX, filed Sep 30, 2026, scored 50 out of 100.
10% owner, ADARx Pharmaceuticals, Inc.
Follow SR ONE CAPITAL MANAGEMENT, LLC, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 30 Form 4 (opens sec.gov) |
ADRXADARx Pharmaceuticals, Inc. · 10% owner10% owner · 5 insiders buying | +25% stake | 50 | $27.2M 1,600,000 at $17.00 |
−13.1% | −14.7% |
Track record (hypothetical): a week after the filing, these buys averaged −13.1% (0% up, 1 measured); a month after, −14.7% (0% up, 1 measured).
Questions
What stock has SR ONE CAPITAL MANAGEMENT, LLC bought?
ADRX (ADARx Pharmaceuticals, Inc.), all on the open market and reported on SEC Form 4.
When did SR ONE CAPITAL MANAGEMENT, LLC last buy?
Sep 30, 2026: 1,600,000 shares of ADRX at $17.00, $27.2M in all (Form 4 (opens sec.gov)).
Has SR ONE CAPITAL MANAGEMENT, LLC filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is SR ONE CAPITAL MANAGEMENT, LLC a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer